Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sunitinib × Endocrine × Clear all

Phase

Status

Completed 10 Terminated 2 Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 18 Breast 5 Thoracic 4 Gastrointestinal 4 CNS 3 Sarcoma 2 Head & Neck 1 Gynecologic 1 Endocrine 1 Dermatologic 1

Conditions

Neoplasm Metastasis 1 Carcinoid Tumor 1

Interventions

lutetium Lu 177 dotatate 6 Everolimus 6 Temozolomide 5 lanreotide 4 anlotinib 4 Dexmedetomidine 4 surufatinib 3 Thyrotropin Alfa 3 Saline Solution 3 Injections 3 Cisplatin 3 Blood Specimen Collection 3 sintilimab 2 penpulimab 2 cabozantinib 2 Surgical Procedures, Operative 2 Sorafenib 2 Sodium Chloride 2 Rosiglitazone 2 Radiotherapy 2 Paclitaxel 2 Nivolumab 2 Lymph Node Excision 2 Liquid Biopsy 2 Fluorodeoxyglucose F18 2 Biopsy 2 177Lu-octreotide, DOTA(0)-Tyr(3)- 2 (177)Lu-DOTA-EB-TATE 2 trametinib 1 toripalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01731925 2017-01-31

SUNLAND

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Unknown

Carcinoid Tumor, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡